You are viewing the site in preview mode

Skip to main content

Advertisement

Figure 3 | BMC Infectious Diseases

Figure 3

From: Protective efficacy of recombinant canine adenovirus type-2 expressing TgROP18 (CAV-2-ROP18) against acute and chronic Toxoplasma gondii infection in mice

Figure 3

Expression analyses of ROP18 protein in transfected MDCK cells by IFA at 48 h post-transfection with a presumptive recombinant virus CAV-2-ROP18: (A) Non-transfected MDCK cells; (B) MDCK cells detected withT. gondii-positive serum post-transfection with a presumptive recombinant virus CAV-2-ROP18. The pictures were showed under 400× microscope.

Back to article page